Antiemetic treatment
- 1 February 1985
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (2) , 155-157
- https://doi.org/10.1016/0277-5379(85)90166-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Extrapyramidal Reactions with High-Dose MetoclopramideNew England Journal of Medicine, 1983
- Delta-9-Tetrahydrocannabinol in Cancer Chemotherapy: Research Problems and IssuesAnnals of Internal Medicine, 1983
- The Pharmacology and Clinical Effectiveness of Phenothiazines and Related Drugs for Managing Chemotherapy-induced EmesisDrugs, 1983
- Behavioral Treatment for the Anticipatory Nausea and Vomiting Induced by Cancer ChemotherapyNew England Journal of Medicine, 1982
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Comparative Trial of the Antiemetic Effects of THC and HaloperidolThe Journal of Clinical Pharmacology, 1981
- Antiemetic Effect of TetrahydrocannabinolArchives of internal medicine (1960), 1980
- Antiemetics in Patients Receiving Chemotherapy for CancerNew England Journal of Medicine, 1980
- Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer ChemotherapyAnnals of Internal Medicine, 1979
- Delta-9-Tetrahydrocannabinol as an Antiemetic in Cancer Patients Receiving High-Dose MethotrexateAnnals of Internal Medicine, 1979